TALKMED GROUP LIMITED SUSTAINABILITY
REPORT
2021
ENGAGING IN
SUSTAINABLE PRACTICES
TALKMED GROUP LIMITED | SUSTAINABILITY REPORT 2021 | 01 |
CONTENTS
About this Report | 2 |
Sustainability Board Statement | 3 |
About TalkMed | 4 |
Sustainability at TalkMed | 7 |
Stakeholder Engagement | 8 |
Materiality Assessment | 9 |
Governance
- Anti-Corruption
Product Responsibility
- Customer Health and Safety
People
- Employment
- Training and Education
Community
GRI Content Index
10
11
12
14
15
16
02 | TALKMED GROUP LIMITED | SUSTAINABILITY REPORT 2021 |
ABOUT THIS REPORT
GRI 102-1|102-46|102-50 | 102-52 | 102-53 | 102-54
TalkMed Group Limited ("TalkMed" or the "Company") is pleased to present our fifth annual Sustainability Report. This report reaffirms our commitment to sustainability and discloses our environmental, social and governance performance for the financial year ended 31 December 2021 ("FY21"). The scope of the report covers our operations in Singapore.
The FY21 Sustainability Report has been prepared in accordance with the Global Reporting Initiative (GRI) Standards: Core option. The GRI standards were chosen as they are the first global standards for sustainability reporting. The GRI Content Index on pages 16 to 19 contains the list of GRI references used in this report. This report is also formed with reference to the primary components set out in Singapore Exchange Limited listing Rule 711B on a 'Comply or Explain' basis.
We value the feedback of our stakeholders and welcome questions you may have on any aspect of our sustainability performance. Please write to:
enquiries@talkmed.com.sg
TALKMED GROUP LIMITED | SUSTAINABILITY REPORT 2021 | 03 |
SUSTAINABILITY BOARD STATEMENT
TalkMed Group is pleased to present our fifth Sustainability Report for the financial year ended 31 December 2021. Our report documents our sustainability performance, progress and the initiatives we have adopted to meet our stakeholders' expectations.
ENVIRONMENT
We are aware of our responsibility to conduct our business in an environmentally responsible manner. We strive to minimise the harmful environmental impacts of our day-today practices and integrate sustainable practices across all business operations. Through sustainability reporting, we would be able to track the progress of our initiatives and create greater environmental consciousness among our community.
At TalkMed, we understand the dangerous effects of improper handling and disposal of medical waste on the environment as well as the society. We are therefore committed to adopt the best practices and ensure compliance with all relevant regulations. This helps minimise the risk of disease transmission, air and water contamination, as well as soil pollution. We hire licensed and experienced firms to collect, transport and dispose of any biohazardous and cytotoxic waste.
SOCIAL
As a medical service provider, we understand the importance of attracting and retaining talented employees to provide exceptional service to our customers. We are committed to enforcing fair labour practices, providing equal opportunities and providing a safe working environment for all our employees.
At TalkMed, we have created a culture that fosters innovation and encourage our medical staff to stay up to date with the latest development in their field. We provide them with diverse training opportunities and support their professional as well as personal development. This helps them to be aware of the latest medical advancement, treatment methods and equipment available in the market and allows them to make well-informed decisions for our customers.
GRI 102-14
Our ultimate goal is to provide quality and safe patient care that exceeds industry standards and responds to the needs of our customers. We believe that maintaining a safe environment is a crucial aspect of competent healthcare. To protect the safety of both patients and our healthcare professionals, we ensure strict adherence to all applicable rules and regulations.
TalkMed values its employees, customers and the community it serves. Our doctors play their part by providing health education to the people. They share their knowledge and contribute to raising disease awareness in Singapore and neighbouring countries via newspapers, magazines, medical journals and medical educational sessions.
COMMUNITY
We strive to have a positive impact on our community and have collaborated with the Singapore Cancer Society to create a difference. As part of our local initiatives, we sponsored and participated in the "Relay for Life" event in Singapore.
GOVERNANCE
We understand our role as a member of the medical fraternity and uphold the highest standards of corporate governance across all our business functions. To demonstrate our commitment to business ethics, we have included anti- corruption as one of the material topics in our report to disclose our practices, policies and performance. We strictly adhere to the compliance requirements of a public listed company and are committed to providing transparent and relevant information to all our stakeholders on a timely basis.
TalkMed believes our responsibility as a healthcare group goes beyond our business operations. We are committed to look for ways to enhance our services and use our resources responsibly. We strive for medical excellence and aim to provide the safest services to our valuable customers. We want to thank our stakeholders for their continuous trust and support in our sustainability journey.
04 | TALKMED GROUP LIMITED | SUSTAINABILITY REPORT 2021 |
ABOUT TALKMED
GRI 102-2 | 102-3|102-4|102-5 | 102-6|102-7 | 102-8
TalkMed and its group of companies (collectively, the "Group") is a premier provider of medical oncology services, stem cell transplant services and palliative healthcare services. We are headquartered in Singapore and our operations extend to serve the markets in Vietnam and Hong Kong as well as the People's Republic of China ("PRC").
TalkMed was incorporated on 10 September 2013 and listed on the Catalist Board of Singapore Exchange Securities Trading Limited on 30 January 2014. TalkMed has transferred its listing from the Catalist to the Mainboard on 28 April 2022. TalkMed's group structure as of May 2022 is as follows:
TalkMed Group
Limited
100% | 100% | 100% | 60% | 30% | |||||||||||||||||
Singapore Cancer | TalkMed Vietnam | TalkMed Greater China | Hong Kong Integrated | ||||||||||||||||||
CellVec Pte. Ltd. | Oncology Centre | ||||||||||||||||||||
Centre Pte. Ltd. | Pte. Ltd. | Pte. Ltd. | |||||||||||||||||||
Holdings Limited | |||||||||||||||||||||
100% | 100% | 69% | |||||||||||||||||||
TalkMed | |||||||||||||||||||||
TalkMed | China | Hong | Kong | ||||||||||||||||||
Chongqing | |||||||||||||||||||||
Pte. | Ltd. | Integrated | |||||||||||||||||||
Pte. Ltd. | |||||||||||||||||||||
Oncology Centre | |||||||||||||||||||||
100% | 90%(a) | 60% | Limited | ||||||||||||||||||
85% | 60% | ||||||||||||||||||||
TalkMed Hospital | Beijing Yachuang | Sino-Singapore | |||||||||||||||||||
Management | Siwei Investment | Hospital Management | Hong Kong | ||||||||||||||||||
Management | |||||||||||||||||||||
(Beijing) Co., Ltd. | (Chongqing) Co., Ltd. | Integrated | Cancer Care | ||||||||||||||||||
Co., Ltd. | |||||||||||||||||||||
Oncology | Consultants | ||||||||||||||||||||
Centre | |||||||||||||||||||||
100% | 30% | 100% | (Kowloon) | Limited | |||||||||||||||||
Chongqing | Limited | ||||||||||||||||||||
Beijing Deyi | |||||||||||||||||||||
Medtech Health | Sino-Singapore | ||||||||||||||||||||
Shanshui Clinic | |||||||||||||||||||||
Management | Cancer Centre | ||||||||||||||||||||
Co., Ltd.(b) | |||||||||||||||||||||
Co., Ltd. | |||||||||||||||||||||
- The Group exercises control over and derives economic benefits from the remaining 10% interest in the entity through contractual arrangements.
- Operates TalkMed Shanshui Medical Centre.
SINGAPORE
Singapore Cancer Centre Pte. Ltd. ("SCC") provides tertiary healthcare services to the oncology patients in the private sector in Singapore, through Parkway Cancer Centre ("PCC"). Our highly-trained doctors attend to patients, examine and administer medical treatments, perform minor outpatient surgical procedures, prescribe medicines and conduct laboratory tests or diagnostic procedures. In addition to the above clinical functions, we review the results of these investigations and provide follow-up patient care.
TalkMed is recognised as one of the leading medical tourism facilities in Singapore. This has been made possible by the excellent medical services provided by our team of sixteen doctors at nine clinics in facilities operated by Parkway Hospitals Singapore Pte. Ltd.. These include Gleneagles Hospital Singapore, Mount Elizabeth Hospital Singapore, Mount Elizabeth Medical Centre and Mount Elizabeth Novena Specialist Centre. For the past few years, SCC has established itself as one of the market leaders in medical tourism in Singapore with foreign patients accounting for approximately half of its patient- load.
CellVec Pte. Ltd. was incorporated on 8 August 2018 and is primarily engaged in the provision of cellular and gene therapy related products and services, with a focus on the development of novel platform viral vector technologies that strive to advance genetic modification of cellular therapy.
In November 2019, TalkMed Greater China Pte. Ltd. was incorporated pursuant to a restructuring exercise to consolidate and streamline the Group's projects in the PRC. It is used by the Group as a vehicle to hold its current projects in Beijing and Chongqing through TalkMed China Pte. Ltd. ("TMC") and TalkMed Chongqing Pte. Ltd. ("TMCQ") respectively as well as to explore future healthcare-related projects collaborations in the PRC.
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Talkmed Group Ltd. published this content on 23 May 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 May 2022 07:25:05 UTC.
